SCHEMBL4043891

SCHEMBL4043891

OCC[CH]c1cccnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP11B1 P15538 1/20 0.48
MAPT P10636 3/20 0.47
MAPK1 P28482 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KDM4E B2RXH2 1/20 0.47
JUN P05412 1/20 0.47
NFKB1 P19838 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
KMT2A Q03164 3/20 0.46
CYP19A1 P11511 2/20 0.46
MEN1 O00255 2/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA7 P36544 1/20 0.45
CHRNA4 P43681 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515423 0.83
SCHEMBL8430953 0.80 CYP11B2 (0.48) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL16586172 0.80 CYP11B2 (0.48) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL5709830 0.80 KMT2A (0.49) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL8200133 0.77 L3MBTL1 (0.49) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL289623 0.77
SCHEMBL3465968 0.77 TBXAS1 (0.49) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL3532314 0.76 TAAR1 (0.55) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL8199623 0.76 CYP11B2 (0.44) CYP11B2ALDH1A1CYP11B1MAPTMAPK1
SCHEMBL8201003 0.76 TDP1 (0.51) CYP11B2ALDH1A1CYP11B1KMT2ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531545-B2 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE) JANSSEN PHARMACEUTICA, N.V. (BE) 2009-05-12 US disclosed
US-20070259898-A1 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) BAXTER ELLEN E 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259898-A1 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) BACE2, PSEN2, BACE1 CYP11B2 4036/4885ALDH1A1 3796/4885CYP11B1 4714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.